Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...
Meanwhile, cities in New Mexico, Minnesota, Kansas, and Utah are leading the pack for cities who are the most open to trying ...
Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.
Singer Lisa Marie Presley's daughter Riley Keough is shedding new light on some of the health challenges her mother faced ...
Mounjaro, the brand name for tirzepatide, is a drug that treats type 2 diabetes by lowering blood sugar levels. According to ...
Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...
With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
The average workplace health insurance plan costs more than $25,000 amid rising prices and expensive weight-loss drugs such ...
Expensive weight-loss drugs like Ozempic, Wegovy are often in short supply. Should we turn to OTC supplements that promise similar benefits.